Cannabinoid industry has been proliferating in the past decade with removal of some regulatory barriers and more favorable political landscape following recent nation-wide legalization in Canada. Major focus of cannabinoid research has been heavily emphasized
‘effectiveness to a higher level.
One of the fundamental challenges of many natural health ingredients including cannabinoids includes its poor bioavailability. Due to its lipophilic nature, human body has hard time absorbing them.
Advanced patent-pending delivery system, Solid State Reactive Mixing (SSRM), invented by Folium Labs presents a novel solution that human bodies can simply absorb more and waste less.
Joint Venture / Licensing
Our SSRM technology is highly versatile and scalable and will allow our partners to offer highly differentiated products for their target consumers.
We are Montreal-based biotechnology company focused on the development and commercialization of proprietary delivery platform that provides enhanced bioavailability and targeted delivery of active ingredients.
Folium Labs Inc. is proud to be among the Top Toronto Pharmaceutical Startups.
BestStartup.ca included Folium Labs on the Top 78 Pharmaceutical Startups and Companies in Toronto
(2021). “These startups and companies are taking a variety of approaches to innovate the Pharmaceutical industry, but are all exceptional companies well worth a follow.
Medicinal mushrooms have been in use for hundreds of years, especially in East Asia. These mushrooms have been marveled for their nutritional value as well as health benefits, including antimicrobial, anti-inflammatory, and anti-cancer abilities .
Folium Labs Inc. is focused on the technologies that drastically enhance bioavailability and efficacy of natural health ingredients and cannabinoids.
SSRM: Patent-pending proprietary technology
Attractive Market Size and Market Growth: TAM over $100B, CAGR 7-9%
Scalability : Versatile technology that can be applied to various ingredients and formats presenting long-term sustainable growth